NY A 11301

in committee

Establishes a framework for regenerative medicine and cell-based therapies

New York · 2025-2026 Regular Session · lower

Quick answers

Did NY A 11301 pass?

Not yet. NY A 11301 is in committee as of 2026-05-11 and has not come to a final vote. Latest recorded action (2026-05-11): REFERRED TO HEALTH

What is NY A 11301 about?

Establishes the "New York regenerative medicine advancement and patient protection act" to build framework for regenerative medicine and cell-based therapies; creates patient protections and disclosure requirements; authorizes limited physician use of qualifying regenerative medicine protocols; creates a regenerative medicine registry; establishes the New York regenerative medicine innovation program.

Who sponsors NY A 11301?

Rules Committee is the primary sponsor of NY A 11301.

Description

Introduced: —
Latest action: 2026-05-11 — REFERRED TO HEALTH
Bill type: bill
Last updated: —

Committees

Not provided by source.

Action timeline

2026-05-11
REFERRED TO HEALTH
referral-committee

Versions

A11301Compare

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

https://legislation.nysenate.gov/api/3/bills/2025-2026/A11301?summary=&detail=

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changes Status and relationship changes

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 11301. See the API docs or the MCP server for AI assistants.

Known limitations

Sponsor party and chamber affiliation are not yet captured by this API.
Committee referrals are not yet captured.

See the methodology page for data sources and limitations.